Advances diabetes and obesity programs with icovamenib demonstrating durable 52-Week Phase II data and with BMF-650, Biomea’s next-generation, ...
Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that five abstracts ? one oral and four poster ...
“This is a very important addition to our mineral portfolio,” stated Mr. Corrado De Gasperis, Comstock’s Executive Chairman and CEO, “as it could conveniently host activities to support the mining at ...
Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and con ...
Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with pembrolizumab alone; study narrowly missed progression ...
The Massachusetts Health Policy Commission (HPC) announced it will hold its Annual Health Care Cost Trends Hearing on November 12, 2025. This ...
Studies evaluating treatment for unresectable hepatocellular carcinoma and metastatic uveal melanoma are highlighted.
As cyber-threats evolve, so must our mindset. In his recent article at SC Media, Jim Routh (an esteemed Institute for ...
As of Nov. 3, LinkedIn is now using data from members in the EU, EEA, Switzerland, Canada, and Hong Kong to train its AI. And ...
LinkedIn was instrumental in shutting down a company scraping its information earlier this year. Now, it is going after ...
Startups.co.uk on MSN
LinkedIn can start using your posts for AI training from this week
The post LinkedIn can start using your posts for AI training from this week appeared first on Startups.co.uk. This week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback